Mechanistic aspects of lauryl gallate-induced differentiation and apoptosis in human acute myeloid leukemia cells

Food and Chemical Toxicology

Volumn 71, Issue , 2014, Pages 197-206

  Teng, Chieh Lin Jerry ^a,b,c   Han, Shao Min ^a,d   Wu, Wei Cheng ^a,e   Hsueh, Chi Mei ^d   Tsai, Jia Rong ^a   Hwang, Wen Li ^a   Hsu, Shih Lan ^a,d,e  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c TUNGHAI UNIVERSITY   (Taiwan)

^d NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^e NATIONAL CHI NAN UNIVERSITY   (Taiwan)

Author keywords

Acute myeloid leukemia; Apoptosis; Differentiation; ERK; Lauryl gallate

Indexed keywords

CASPASE 2; CASPASE 3; CASPASE 8; CASPASE 9; CD14 ANTIGEN; DEATH RECEPTOR 4; DEATH RECEPTOR 5; DODECYL GALLATE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BAK; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN MCL 1; PUMA PROTEIN; TRANSCRIPTION FACTOR SP1; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; LIPOCORTIN 5; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN; GALLIC ACID; TUMOR PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL DIFFERENTIATION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IC 50; LEUKEMIA CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MONOCYTE; MYELOID LEUKEMIA CELL LINE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; ANTIPROLIFERATIVE ACTIVITY; CELL CYCLE G1 PHASE; HL 60 CELL LINE; IC50; KG 1 CELL LINE; NITROBLUE TETRAZOLIUM TEST; ACUTE MYELOBLASTIC LEUKEMIA; ANALOGS AND DERIVATIVES; DRUG EFFECTS; METABOLISM; PATHOLOGY;

APOPTOSIS; CELL DIFFERENTIATION; GALLIC ACID; HL-60 CELLS; HUMANS; LEUKEMIA, MYELOID, ACUTE; NEOPLASM PROTEINS;

EID: 84904101387     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2014.06.019     Document Type: Article

References (37)

1. Bellail A.C., Qi L., Mulligan P., Chhabra V., Hao C. TRAIL agonists on clinical trials for cancer therapy: the promises and the challenges. Rev. Recent Clin. Trials 2009, 4:34-41.
2. Burnett A., Wetzler M., Lowenberg B. Therapeutic advances in acute myeloid leukemia. J. Clin. Oncol.: Official J. Am. Soc. Clin. Oncol. 2011, 29:487-494.
3. Calcabrini A., Garcia-Martinez J.M., Gonzalez L., Tendero M.J., Ortuno M.T., Crateri P., Lopez-Rivas A., Arancia G., Gonzalez-Porque P., Martin-Perez J. Inhibition of proliferation and induction of apoptosis in human breast cancer cells by lauryl gallate. Carcinogenesis 2006, 27:1699-1712.
4. Curry J.M., Eubank T.D., Roberts R.D., Wang Y., Pore N., Maity A., Marsh C.B. M-CSF signals through the MAPK/ERK pathway via Sp1 to induce VEGF production and induces angiogenesis in vivo. PLoS ONE 2008, 3:e3405.
5. de Cordova C.A., Locatelli C., Assuncao L.S., Mattei B., Mascarello A., Winter E., Nunes R.J., Yunes R.A., Creczynski-Pasa T.B. Octyl and dodecyl gallates induce oxidative stress and apoptosis in a melanoma cell line. Toxicology In Vitro: Int. J. Publish. Assoc. BIBRA 2011, 25:2025-2034.
6. Elrod H.A., Sun S.Y. Modulation of death receptors by cancer therapeutic agents. Cancer Biol. Ther. 2008, 7:163-173.
7. Hughes P.J., Marcinkowska E., Gocek E., Studzinski G.P., Brown G. Vitamin D3-driven signals for myeloid cell differentiation-implications for differentiation therapy. Leuk. Res. 2010, 34:553-565.
8. Hurtado C., Bustos M.J., Sabina P., Nogal M.L., Granja A.G., Gonzalez M.E., Gonzalez-Porque P., Revilla Y., Carrascosa A.L. Antiviral activity of lauryl gallate against animal viruses. Antiviral Ther. 2008, 13:909-917.
9. Koeffler H.P. Is there a role for differentiating therapy in non-APL AML? Best practice & research. Clin. Haematol. 2010, 23:503-508.
10. Koschmieder S., Agrawal S., Radomska H.S., Huettner C.S., Tenen D.G., Ottmann O.G., Berdel W.E., Serve H.L., Muller-Tidow C. Decitabine and vitamin D3 differentially affect hematopoietic transcription factors to induce monocytic differentiation. Int. J. Oncol. 2007, 30:349-355.
11. Kubo I., Masuoka N., Xiao P., Haraguchi H. Antioxidant activity of dodecyl gallate. J. Agri. Food Chem. 2002, 50:3533-3539.
12. Kubo I., Fujita K., Nihei K., Nihei A. Antibacterial activity of akyl gallates against Bacillus subtilis. J. Agri. Food Chem. 2004, 52:1072-1076.
13. MacKenzie S.H., Clark A.C. Death by caspase dimerization. Adv. Exp. Med. Biol. 2012, 747:55-73.
14. Miranda M.B., McGuire T.F., Johnson D.E. Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines. Leukemia 2002, 16:683-692.
15. Murthy S., Ryan A.J., Carter A.B. SP-1 regulation of MMP-9 expression requires Ser586 in the PEST domain. Biochem. J. 2012, 445:229-236.
16. Ortega E., Sadaba M.C., Ortiz A.I., Cespon C., Rocamora A., Escolano J.M., Roy G., Villar L.M., Gonzalez-Porque P. Tumoricidal activity of lauryl gallate towards chemically induced skin tumours in mice. Br. J. Cancer 2003, 88:940-943.
17. Palacios C., Cespon C., Martin De La Vega C., Roy G., Serrano A., Salinas M., Gonzalez-Porque P. Lauryl gallate inhibits the activity of protein tyrosine kinase c-Src purified from human platelets. J. Enzym. Inhib. 2001, 16:527-533.
18. Pan Z., Hetherington C.J., Zhang D.E. CCAAT/enhancer-binding protein activates the CD14 promoter and mediates transforming growth factor beta signaling in monocyte development. J. Biol. Chem. 1999, 274:23242-23248.
19. Park S.Y., Shin H.M., Han T.H. Synergistic interaction of MEF2D and Sp1 in activation of the CD14 promoter. Mol. Immunol. 2002, 39:25-30.
20. Reilly J.T. Pathogenesis of acute myeloid leukaemia and inv(16)(p13;q22): a paradigm for understanding leukaemogenesis?. Br. J. Haematol. 2005, 128:18-34.
21. Robak T., Wierzbowska A. Current and emerging therapies for acute myeloid leukemia. Clin. Ther. 2009, 31(Pt 2):2349-2370.
22. Roy G., Lombardia M., Palacios C., Serrano A., Cespon C., Ortega E., Eiras P., Lujan S., Revilla Y., Gonzalez-Porque P. Mechanistic aspects of the induction of apoptosis by lauryl gallate in the murine B-cell lymphoma line Wehi 231. Arch. Biochem. Biophys. 2000, 383:206-214.
23. Saeki K., Yuo A., Isemura M., Abe I., Seki T., Noguchi H. Apoptosis-inducing activity of lipid derivatives of gallic acid. Biol. Pharm. Bull. 2000, 23:1391-1394.
24. Scott S.A., Dong W.F., Ichinohasama R., Hirsch C., Sheridan D., Sanche S.E., Geyer C.R., Decoteau J.F. 5-Aza-2'-deoxycytidine (decitabine) can relieve p21WAF1 repression in human acute myeloid leukemia by a mechanism involving release of histone deacetylase 1 (HDAC1) without requiring p21WAF1 promoter demethylation. Leuk. Res. 2006, 30:69-76.
25. Serrano A., Palacios C., Roy G., Cespon C., Villar M.L., Nocito M., Gonzalez-Porque P. Derivatives of gallic acid induce apoptosis in tumoral cell lines and inhibit lymphocyte proliferation. Arch. Biochem. Biophys. 1998, 350:49-54.
26. Shaul Y.D., Seger R. The MEK/ERK cascade: from signaling specificity to diverse functions. Biochim. Biophys. Acta 2007, 1773:1213-1226.
27. Soria J.C., Blay J.Y., Spano J.P., Pivot X., Coscas Y., Khayat D. Added value of molecular targeted agents in oncology. Ann. Oncol.: Official J. Eur. Soc. Med. Oncol./ESMO 2011, 22:1703-1716.
28. Teng C.L., Yu C.T., Hwang W.L., Tsai J.R., Liu H.C., Hwang G.Y., Hsu S.L. Effector mechanisms of sunitinib-induced G1 cell cycle arrest, differentiation, and apoptosis in human acute myeloid leukaemia HL60 and KG-1 cells. Ann. Hematol. 2013, 92:301-313.
29. Thompson T., Danilenko M., Vassilev L., Studzinski G.P. Tumor suppressor p53 status does not determine the differentiation-associated G(1) cell cycle arrest induced in leukemia cells by 1,25-dihydroxyvitamin D(3) and antioxidants. Cancer Biol. Ther. 2010, 10:344-350.
30. van der Heijden C.A., Janssen P.J., Strik J.J. Toxicology of gallates: a review and evaluation. Food Chem. Toxicol.: Int. J. Publish. Br. Indus. Biol. Res. Ass. 1986, 24:1067-1070.
31. Vardiman J.W., Thiele J., Arber D.A., Brunning R.D., Borowitz M.J., Porwit A., Harris N.L., Le Beau M.M., Hellstrom-Lindberg E., Tefferi A., Bloomfield C.D. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009, 114:937-951.
32. Wang Z.Y., Chen Z. Acute promyelocytic leukemia: from highly fatal to highly curable. Blood 2008, 111:2505-2515.
33. Wen C.L., Teng C.L., Chiang C.H., Chang C.C., Hwang W.L., Kuo C.L., Hsu S.L. Methanol extract of Antrodia cinnamomea mycelia induces phenotypic and functional differentiation of HL60 into monocyte-like cells via an ERK/CEBP-beta signaling pathway. Phytomed.: Int. J. Phytother. Phytopharm. 2012, 19:424-435.
34. Wortzel I., Seger R. The ERK cascade: distinct functions within various subcellular organelles. Genes Cancer 2011, 2:195-209.
35. Yam L.T., Li C.Y., Crosby W.H. Cytochemical identification of monocytes and granulocytes. Am. J. Clin. Pathol. 1971, 55:283-290.
36. Yen A., Roberson M.S., Varvayanis S., Lee A.T. Retinoic acid induced mitogen-activated protein (MAP)/extracellular signal-regulated kinase (ERK) kinase-dependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrest. Cancer Res. 1998, 58:3163-3172.
37. Zhang D.E., Hetherington C.J., Tan S., Dziennis S.E., Gonzalez D.A., Chen H.M., Tenen D.G. Sp1 is a critical factor for the monocytic specific expression of human CD14. J. Biol. Chem. 1994, 269:11425-11434.